Skip to main content

Table 1 Treatment groups, dosage and schedule of administration of perioperative dDAVP

From: A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients

Group

First dose (µg/kg) 30–60 min before surgery

Second dose (µg/kg) 24 h after surgery

Total dose (µg/kg)

1

0.25

0.25

0.5

2

0.5

0.5

1.0

3

0.75

0.5

1.25

4

1.0

0.5

1.5

5

1.0

1.0

2.0